← SynDRA
HALOBETASOL PROPIONATE
SynDRA canonical compound SYN0023269 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | NR3C1 | PLA2G1B |
|---|
| Mechanism of action | glucocorticoid receptor agonist |
|---|
| Indication | corticosteroid-responsive dermatoses |
|---|
| Disease area | dermatology |
|---|
All known targets
- NR3C1
- ESRRA
- ESRRB
- ESRRG
- PLA2G1B
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AR
- PGR
- ACHE
- KCNH2
- TBXA2R
- SLC6A4
- SLC6A3
- SLC6A2
- PTGS1
- PDE4A
- PDE3A
- OPRM1
- MAOA
- KDR
- HTR2B
- ADORA3
- HTR1A
- HRH3
- HDAC6
- F2
- ESR1
- DRD3
- DRD1
- CHRM2
- CHRM1
- ADRA2A
- ADRA1A
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Cardiovascular Agents
- Vasoconstrictor Agents
ATC classes
- D07A · CORTICOSTEROIDS, PLAIN
- ANTIPSORIATICS FOR TOPICAL USE
Cross-references
Synonyms
- BRYHALI
- Bryhali
- DUOBRII
- HALOBETASOL PROPIONATE AND TAZAROTENE
- LEXETTE
- Lexette
- ULTRAVATE
- Ultravate
- ulobetasol propionate
- miracorten
- Ulobetasol
- Ulobetasol propionate
- 21-chloro diflorasone
- Halobetasol
- Jemdel
- BMY-30056
- CGP-14,458
- CGP-14458
- IDP-122
- Halobetasol propionate component of duobrii
- Halobetasol propionate component of idp-118
- Miracorten
- Halobetasol propionate [USAN]
- Ulobetasol cream
- CGP 14 458
- Halobetasol propionate (USAN)
- Ultravate (TN)
- 6 alpha-fluoroclobetasol 17-propionate
- 6-fluoroclobetasol 17-propionate
- halobetasol.propionate
- Halobetasol (propionate)
- BMY 30056
- 91A0K1TY3Z
- UNII-91A0K1TY3Z
- NCGC00167451-01
- Halobetasol propionate [USAN:USP]
Look up HALOBETASOL PROPIONATE in the interactive SynDRA portal →